Quantcast

Latest Brain tumor Stories

2014-07-25 23:03:22

Experts at the American Brain Tumor Association’s annual conference report findings and dispel myths Chicago, IL (PRWEB) July 25, 2014 Today, nearly 700,000 people in the U.S. are living with a brain tumor, and yet, when it comes to pinpointing causes or risk factors, scientists are still searching for answers. “Right now, we don’t know who, we don’t know when, and we don’t know why people develop brain tumors,” said Elizabeth M. Wilson, MNA, president & CEO, American...

2014-07-25 23:03:18

Harvard Neuro-Oncologist presents latest brain tumor research and treatment options at American Brain Tumor Association’s annual conference. Chicago, IL (PRWEB) July 25, 2014 Progress in understanding the molecular genetics of brain tumors has ushered in a new era of promising brain tumor treatments, according to Patrick Wen, MD, professor of neurology, Harvard Medical School, director of the Center for Neuro-Oncology, Dana-Farber Cancer Institute. At the American Brain Tumor...

2014-07-24 16:27:44

Company's fiscal year will change from December 31 to June 30 VANCOUVER, British Columbia and MENLO PARK, Calif., July 24, 2014 /PRNewswire/ -- DelMar Pharmaceuticals, Inc. (OTCQB: DMPI) ("DelMar" "the company") announced today that the company's board of directors approved a change of the company's fiscal year from December 31 to June 30. Accordingly, DelMar will file a Transition Form 10K on or before September 30, 2014. Jeffrey Bacha, president and CEO of DelMar stated, "The...

2014-07-24 16:24:49

Tony Danza Appointed as Master of Ceremonies for the Charitable Event NEW YORK, July 24, 2014 /PRNewswire-USNewswire/ -- Voices Against Brain Cancer, in partnership with New York Road Runners, will host its annual "Join The Voices! New York Run/Walk" on Sunday, August 10, 2014 at The Naumburg Bandshell in Central Park at 8:30 a.m. The charitable event, which last year raised close to one million dollars, will feature a five-mile run, a scenic walk, kids races and a fun family festival....

2014-07-22 12:30:35

BOSTON, July 22, 2014 /PRNewswire/ -- Vittamed Corporation, a neurodiagnostics medical device company based in Boston with R&D in Lithuania, today announced it has received the CE Mark of approval for two novel neuromonitoring devices: the Vittamed 205 for non-invasive intracranial pressure (ICP) measurement and the Vittamed 505 for non-invasive Cerebrovascular autoregulation monitoring. "CE approval for both devices is not only an important milestone for our company as we move...

2014-07-15 08:28:10

Physicians at 15 leading brain cancer centers in 8 countries certified to provide NovoTTF Therapy to recurrent glioblastoma patients on prescription order LUCERNE, Switzerland, July 15, 2014 /PRNewswire/ -- Novocure, a commercial stage oncology company, announced today that 18 prominent neurosurgeons and neuro-oncologists at medical centers in Europe and Israel are trained and certified to prescribe NovoTTF Therapy. These physicians will now be able to treat recurrent glioblastoma...

2014-07-12 23:02:37

ResearchMoz presents this most up-to-date research on Critical Care Therapeutics in Major Developed Markets to 2020 - New and Late-Stage Four-Factor PCCs and Recombinant Products to Drive Market. View All Therapeutic Area Market Research Reports at http://www.researchmoz.us/therapeutic-area-market-reports-37.html. Albany, NY (PRWEB) July 12, 2014 “Critical Care Therapeutics in Major Developed Markets to 2020 - New and Late-Stage Four-Factor PCCs and Recombinant Products to Drive...

2014-07-11 23:09:19

Capital Institute for Neurosciences Begins Clinical Trial Delivering Chemotherapy Directly to Brain Tumors Starting with Incision in Leg Hopewell, NJ (PRWEB) July 11, 2014 The Capital Institute for Neurosciences at Capital Health today announced it has performed the first procedure in a clinical trial that delivers chemotherapy to brain tumors through a catheter inserted in the leg. During the procedure, done at Capital Health Medical Center – Hopewell, Dr. Erol Veznedaroglu, an...

2014-07-09 23:08:02

Renowned Experts Gather to Review Brain Tumor Cases, Give Inside Look into Tumor Board Experience Chicago, IL (PRWEB) July 09, 2014 With more than 120 types of brain tumors, there is no one-size-fits all approach to treatment. That is why in some instances, physicians engage the expertise of colleagues across specialties for discussion of a particular case. This multidisciplinary group is called a “tumor board” and is where these physicians can discuss each case to define the optimal...

2014-07-09 11:17:04

NIH/National Institute of Neurological Disorders and Stroke NIH-funded researchers find brain tumor cells disrupt the brain's protective barrier, offering potential avenues for therapy Invading glioblastoma cells may hijack cerebral blood vessels during early stages of disease progression and damage the brain's protective barrier, a study in mice indicates. This finding could ultimately lead to new ways to bring about the death of the tumor, as therapies may be able to reach these...


Word of the Day
omadhaun
  • A fool; a simpleton: a term of abuse common in Ireland and to a less extent in the Gaelic-speaking parts of Scotland.
This word is partly Irish in origin.